Genesis Capital
VC Fund
Atlanta, United States
Genesis Capital is an independent investment and merchant banking firm focused on key growth sectors of the economy. Genesis Capital provides a comprehensive range of services including mergers, acquisitions, sales, and capital raising. We are selective about taking on engagements and focus where our expertise and unique approach will maximize thegoals and objectives for our clients and partners.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Genesis Capital invests in
Stages Genesis Capital invests in
Countries Genesis Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jonathan Goldman
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 2 (50%)
- EdTech 1 (25%)
- Wellness 1 (25%)
- Education 1 (25%)
- Medical Device 1 (25%)
Stage
- Series A 2 (50%)
- Series B 1 (25%)
- Series F 1 (25%)
Country
- China 2 (50%)
- United States 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jonathan Goldman
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Reprieve Cardiovascular
|
Reprieve Cardiovascular is a pioneering medical device company focused on innovative fluid management technologies for congestive heart failure. The company's Reprieve technology is being investigated as an innovative fluid management treatment. Providing clinicians with the ability to precisely control a patient’s fluid volume may both enableimproved cardiac care, as well as, be instrumental in the decongestion of acutely decompensated heart failure patients (ADHF). Reprieve Cardiovascular, Inc. and RenalGuard Solutions, Inc. are subsidiaries of parent company CardioRenal Systems, Inc. | $61M / Series B / Aug 13, 2025 | |
|
Reprieve Cardiovascular
|
Reprieve Cardiovascular is a pioneering medical device company focused on innovative fluid management technologies for congestive heart failure. The company's Reprieve technology is being investigated as an innovative fluid management treatment. Providing clinicians with the ability to precisely control a patient’s fluid volume may both enableimproved cardiac care, as well as, be instrumental in the decongestion of acutely decompensated heart failure patients (ADHF). Reprieve Cardiovascular, Inc. and RenalGuard Solutions, Inc. are subsidiaries of parent company CardioRenal Systems, Inc. | $42M / Series A / Feb 20, 2024 | |
Nutshell Therapeutics
|
Inventing small molecule in the realm of drug discovery fostered by protein dynamics. | $40M / Series A / Mar 14, 2022 | |
Zhangmen
|
Zhangmen is an online tutoring platform provides tutoring courses to students. Through the online and mobile apps of Zhangmen, primary and middle school students from eight to 18 years old can select top teachers who have graduated from China’s first-class universities such as Tsinghua, Peking University, and Fudan, for personalized, one-on-onetutoring sessions. They provided online education services in a one-to-one comprehensive transformation. | $400M / Series F / Oct 01, 2020 |
Co-Investors
Arboretum Ventures
2 deals together
Deerfield Management
2 deals together
Lightstone Ventures
2 deals together
Sante Ventures
2 deals together
Cadence Healthcare Ventures
1 deal together
CPP Investments
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Genesis Capital invest in?
Genesis Capital invests primarily in Health Care, EdTech and Wellness startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Genesis Capital?
Public channels for Genesis Capital include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Genesis Capital?
The team at Genesis Capital includes Jonathan Goldman (Founder and Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
